India to Kenya: Vati Export Trade Route
India has recorded 156 verified shipments of Vati exported to Kenya, representing a combined trade value of $639.5K USD. This corridor is served by 28 active Indian exporters, with an average shipment value of $4.1K USD. The leading Indian exporter is LABORATE PHARMACEUTICALS INDIA LTD, which accounts for 71% of total export value with 40 shipments worth $453.6K USD. On the buying side, INVESTMENT & MORTGAGES BANK LTD. is the largest importer in Kenya with $178.6K USD in purchases. The top 3 suppliers — LABORATE PHARMACEUTICALS INDIA LTD, LABORATE PHARMACEUTICALS INDIA LIMITED, LABORATE PHARMACEUTICAL INDIA LIMITED — together control 91% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Vati corridor is one of India's established pharmaceutical export routes, with 156 shipments documented worth a combined $639.5K USD. The route is dominated by LABORATE PHARMACEUTICALS INDIA LTD, which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's vati manufacturing sector.
Across 28 active suppliers, the average shipment value stands at $4.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with vati's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 29.1%, placing it at rank #14 among India's top vati export destinations globally.
On the import side, key buyers of Indian vati in Kenya include INVESTMENT & MORTGAGES BANK LTD., HEALTHCARE LTD, ROYAL PHARMA 2011 LTD. (UGANDA) and 37 others. INVESTMENT & MORTGAGES BANK LTD. is the single largest importer with 34 shipments valued at $178.6K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ3
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#14
- Annual growth+29.1%
- Demand growth+26.2%
- Regulatory ease84/100
Top 10 Indian Vati Exporters to Kenya
Showing top 10 of 28 Indian suppliers exporting Vati to Kenya, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LABORATE PHARMACEUTICALS INDIA LTD Avg $11.3K per shipment | 40 | $453.6K | 70.9% |
| 2 | LABORATE PHARMACEUTICALS INDIA LIMITED Avg $8.3K per shipment | 8 | $66.5K | 10.4% |
| 3 | LABORATE PHARMACEUTICAL INDIA LIMITED Avg $16.1K per shipment | 4 | $64.3K | 10.1% |
| 4 | INTAS PHARMACEUTICALS LIMITED Avg $9.9K per shipment | 1 | $9.9K | 1.5% |
| 5 | ASPIDA LIFE SCIENCES PRIVATE LIMITED Avg $719 per shipment | 10 | $7.2K | 1.1% |
| 6 | R.S. SURGIPHARM PRIVATE LIMITED Avg $545 per shipment | 13 | $7.1K | 1.1% |
| 7 | MANKIND PHARMA LIMITED Avg $5.4K per shipment | 1 | $5.4K | 0.8% |
| 8 | R S SURGIPHARM PRIVATE LIMITED Avg $928 per shipment | 4 | $3.7K | 0.6% |
| 9 | GUDHKA BROTHERS Avg $1.2K per shipment | 3 | $3.5K | 0.5% |
| 10 | 3S CORPORATION Avg $646 per shipment | 5 | $3.2K | 0.5% |
This table shows the top 10 of 28 Indian companies exporting vati to Kenya, ranked by total trade value. The listed exporters are: LABORATE PHARMACEUTICALS INDIA LTD, LABORATE PHARMACEUTICALS INDIA LIMITED, LABORATE PHARMACEUTICAL INDIA LIMITED, INTAS PHARMACEUTICALS LIMITED, ASPIDA LIFE SCIENCES PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED, MANKIND PHARMA LIMITED, R S SURGIPHARM PRIVATE LIMITED, GUDHKA BROTHERS, 3S CORPORATION . LABORATE PHARMACEUTICALS INDIA LTD is the dominant supplier with 40 shipments worth $453.6K USD, giving it a 71% market share. The top 3 suppliers together account for 91% of the total trade value on this route.
Showing top 10 of 28 total Indian exporters on the India to Kenya Vati export route.
Top 10 Vati Importers in Kenya
Showing top 10 of 40 known buyers in Kenya receiving Vati shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian vati in Kenya include INVESTMENT & MORTGAGES BANK LTD., HEALTHCARE LTD, ROYAL PHARMA 2011 LTD. (UGANDA), KAMCARE PHARMA LTD, TO THE ORDER OF ROYAL PHARMA 2011 L, among 40 total buyers. The largest importer is INVESTMENT & MORTGAGES BANK LTD., accounting for $178.6K USD across 34 shipments — representing 28% of all vati imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INVESTMENT & MORTGAGES BANK LTD. | 34 | $178.6K | 27.9% |
| 2 | HEALTHCARE LTD | 3 | $83.8K | 13.1% |
| 3 | ROYAL PHARMA 2011 LTD. (UGANDA) | 1 | $73.8K | 11.5% |
| 4 | KAMCARE PHARMA LTD | 1 | $58.2K | 9.1% |
| 5 | TO THE ORDER OF ROYAL PHARMA 2011 L | 1 | $53.5K | 8.4% |
| 6 | ROYAL PHARMA 2011 LTD. | 1 | $48.4K | 7.6% |
| 7 | NOVOMED HEALTHCARE LTD. | 1 | $29.9K | 4.7% |
| 8 | INVESTMENT MORTGAGES BANK LIMITED | 3 | $25.4K | 4.0% |
| 9 | INVESTMENT & MORTGAGES BANK LIMITED | 6 | $21.6K | 3.4% |
| 10 | CROWN SOLUTION LIMITED | 1 | $11.2K | 1.8% |
Showing top 10 of 40 Vati importers in Kenya on this route.
Top 10 Vati Formulations Imported by Kenya
Showing top 10 of 98 product formulations shipped on the India to Kenya Vati route, ranked by trade value
Kenya imports a wide range of vati formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — 1-2113 DICLOFENAC SODIUM INJ 3ml (Diclofenac Sodium BP 25mg/ml, Benzyl Alcohol BP (as preservative) 4%v/v) (QTY: 42260 B — accounts for $73.8K USD across 1 shipments. There are 98 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | 1-2113 DICLOFENAC SODIUM INJ 3ml (Diclofenac Sodium BP 25mg/ml, Benzyl Alcohol BP (as preservative) 4%v/v) (QTY: 42260 B | 1 | $73.8K | 11.5% |
| 2 | 1-300 MALAREST INJECTION 2ML (Quinine Dihydrochloride 300mg/ml, Benzyl Alcohol (as preservative) 2%w/v) BatchNos:OQDIE-0 | 1 | $58.2K | 9.1% |
| 3 | 1 740 DICLOFENAC SODIUM INJ 3ml Diclofenac Sodium BP 25mg ml Benzyl Alcohol BP as preservative 4 v v QTY 14800 BO | 1 | $53.5K | 8.4% |
| 4 | 1-1400 DICLOFENAC SODIUM INJ 3ml (Diclofenac Sodium BP 25mg/ml, Benzyl Alcohol BP (as preservative) 4%v/v) (QTY: 28000 B | 1 | $48.4K | 7.6% |
| 5 | 145 294 MALAREST INJECTION 2ML Quinine Dihydrochloride 300mg ml Benzyl Alcohol as preservative 2 w v BatchNos MMRIE 0 | 1 | $39.1K | 6.1% |
| 6 | 210-359 MALAREST INJECTION 2MLQuinine Dihydrochloride 300mg/ml, Benzyl Alcoholas preservative 2%w/v BatchNos:NMRIE- | 1 | $38.9K | 6.1% |
| 7 | 1082-1576 ARCELIA GENTAMICIN SULPHATE INJ 2ML (Gentamicin Sulphate 40mg/ml,Methyl paraben(as preservative) 0.18%w/v,Prop | 1 | $29.9K | 4.7% |
| 8 | 351-938 DICLOFENAC SODIUM INJ 3ML (Diclofenac Sodium BP 25mg/ml, Benzyl AlcoholBP (as preservative) 4%v/v) (QTY: 117600 | 1 | $25.3K | 3.9% |
| 9 | 201-600 DICLOFENAC SODIUM INJ 3ML(DICLOFENAC SODIUM 25MG/ML, BENZYL ALCOHOL (ASPRESERVATIVE) 4%V/V) BATCHNOS:ODSIE-016 | 1 | $17.1K | 2.7% |
| 10 | 1-75 QUININE INJECTION 2ML(Quinine Dihydrochloride BP 300mg/ml, Benzyl Alcohol BP (as preservative) 2%w/v) (QTY:150000 A | 1 | $14.7K | 2.3% |
Showing top 10 of 98 Vati formulations imported by Kenya on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 38 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's vati exports to Kenya are driven primarily by a handful of large-scale manufacturers. LABORATE PHARMACEUTICALS INDIA LTD with 40 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 28 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LABORATE PHARMACEUTICALS INDIA LTD, LABORATE PHARMACEUTICALS INDIA LIMITED, LABORATE PHARMACEUTICAL INDIA LIMITED — together account for 91% of total trade value on this route. The average shipment value of $4.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as 1-300 malarest injection 2ml (quinine dihydrochloride 300mg/ml, benzyl alcohol (as preservative) 2%w/v) batchnos:oqdie-0 and 1 740 diclofenac sodium inj 3ml diclofenac sodium bp 25mg ml benzyl alcohol bp as preservative 4 v v qty 14800 bo, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, INVESTMENT & MORTGAGES BANK LTD. is the largest importer with 34 shipments worth $178.6K USD — representing 28% of all vati imports from India on this route. A total of 40 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $639.5K
- Avg. Shipment
- $4.1K
- Suppliers
- 28
- Buyers
- 40
- Transit (Sea)
- ~21 days
- Annual Growth
- +29.1%
Other Vati Routes
Unlock the Full India to Kenya Vati Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 156 shipments on this route.
Frequently Asked Questions — India to Kenya Vati Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Vati to Kenya?
The leading Indian exporters of Vati to Kenya are LABORATE PHARMACEUTICALS INDIA LTD, LABORATE PHARMACEUTICALS INDIA LIMITED, LABORATE PHARMACEUTICAL INDIA LIMITED. LABORATE PHARMACEUTICALS INDIA LTD holds the largest market share at approximately 71% of total trade value on this route.
Q What is the total value of Vati exports from India to Kenya?
India exports Vati to Kenya worth approximately $639.5K USD across 156 recorded shipments. The average value per shipment is $4.1K USD.
Q Which ports does India use to ship Vati to Kenya?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 38 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Kenya for Vati?
The average transit time for Vati shipments from India to Kenya is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Kenya Vati trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.1% with demand growth tracking at 26.2%. The route is ranked #14 among India's top Vati export destinations globally.
Q How many suppliers are active on the India to Kenya Vati route?
There are currently 28 active Indian suppliers exporting Vati to Kenya. The market is moderately concentrated with LABORATE PHARMACEUTICALS INDIA LTD accounting for 71% of total shipment value.
Q Who are the main importers of Vati from India in Kenya?
The leading importers of Indian Vati in Kenya include INVESTMENT & MORTGAGES BANK LTD., HEALTHCARE LTD, ROYAL PHARMA 2011 LTD. (UGANDA), KAMCARE PHARMA LTD, TO THE ORDER OF ROYAL PHARMA 2011 L. INVESTMENT & MORTGAGES BANK LTD. is the largest buyer with 34 shipments worth $178.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Kenya export trade corridor identified from Indian Customs (DGFT) records for Vati.
- 2.Supplier/Buyer Matching: 28 Indian exporters and 40 importers in Kenya matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 156 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
156 Verified Shipments
28 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists